TMN 355 structure
|
Common Name | TMN 355 | ||
---|---|---|---|---|
CAS Number | 1186372-20-2 | Molecular Weight | 380.79900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H14ClFN2O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of TMN 355TMN355 is a potent chemical cyclophilin A inhibitor and reduces foam cell formation and cytokine secretion. TMN355 is used for atherosclerosis[1]. |
Name | 1-(2-chloro-6-fluorobenzoyl)-3-(9H-fluoren-9-yl)-urea |
---|---|
Synonym | More Synonyms |
Description | TMN355 is a potent chemical cyclophilin A inhibitor and reduces foam cell formation and cytokine secretion. TMN355 is used for atherosclerosis[1]. |
---|---|
Related Catalog | |
Target |
cyclophilin A[1] |
In Vitro | TMN 355 (0.5-10 μM; 3-9 hours) results in 75.9% reduction of cyclophilin A protein expression. And 1 μM TMN 355 inhibits cyclophilin A after 6 h of activation[1]. Western Blot Analysis[1] Cell Line: THP cell lines Concentration: 0.5, 1, 2.5, 5 and 10 μM Incubation Time: 3, 6 and 9 hours Result: Resulted in 75.9% reduction of cyclophilin A protein expression. |
References |
Molecular Formula | C21H14ClFN2O2 |
---|---|
Molecular Weight | 380.79900 |
Exact Mass | 380.07300 |
PSA | 58.20000 |
LogP | 5.47030 |
Hazard Codes | Xi |
---|
2-Chloro-N-[(9H-fluoren-9-ylamino)carbonyl]-6-fluorobenzamide |